|
Feb 18
|
|
$25.45
$25.45
+0.0%
|
N/A
|
Finnhub News
|
— |
Finnhub - DOCS
Canaccord Calls Doximity, Inc. (DOCS)’s Post-...
|
|
Feb 16
|
|
$25.02
$25.45
+1.7%
|
N/A
|
Finnhub News
|
— |
Finnhub - DOCS
Doximity Inc. (NYSE:DOCS) Fits the "Affordabl...
|
|
Feb 14
|
|
$25.02
$25.45
+1.7%
|
SHORT
|
Finnhub News
|
The stock is down significantly after mixed earnings signals, prompting a reevaluation of its positive outlook. |
Finnhub - DOCS
Doximity (DOCS) Is Down 9.8% After Big Buybac...
|
|
Feb 13
|
|
$25.02
$25.45
+1.7%
|
LONG
|
Dmitry Solodin
Trader / Investor
|
Doximity stock has crashed, but fundamentals remain robust: 20% revenue growth, rising EPS, and P/E around 20x. It operates a "sticky" platform for medical professionals (the "LinkedIn for Doctors"). The crash is a technical "falling knife" into a long-term accumulation zone. The business model is not broken, making this a value entry point. LONG. A long-term compounder currently on sale. Catching a falling knife; volatility remains high. |
Dmitry Solodin
Почему упали ИНФОТЕХИ и стоит ли их ПОКУПАТЬ?...
|
|
Feb 13
|
|
$25.02
$25.45
+1.7%
|
NEUTRAL
|
Finnhub News
|
The headline poses a question regarding the investment recommendation for Tempus AI stock ahead of its Q4 earnings report. |
Finnhub - DOCS
Should You Buy, Hold or Sell Tempus AI Stock ...
|